CHINA RES.PHARMA.GRP O.N. revenue breakdown overview

CHINA RES.PHARMA.GRP O.N. revenue for the last year amounted to 34.09 B EUR, the most of which — 22.72 B EUR — came from its highest performing source at the moment, Distribution, the year earlier bringing 24.53 B EUR. The greatest contribution to the revenue figure was made by China — last year it brought CHINA RES.PHARMA.GRP O.N. 28.20 B EUR, and the year before that — 30.32 B EUR.